Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tPA and Captopril for Angiostatin Generation in Metastatic Cancer
NCT00086723Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jul 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tissue-plasminogen activator and captopril in solid tumor, sponsored by Northwestern University. Primary endpoints: Maximum Tolerated Dose, Toxicity and 1 more. Started Jul 2003; status: completed.
02
Drugs
tissue-plasminogen activatorcaptopril
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00086723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086723.